These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12490597

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor.
    Sharif NA, Davis TL, Williams GW.
    J Pharm Pharmacol; 1999 Jun; 51(6):685-94. PubMed ID: 10454045
    [Abstract] [Full Text] [Related]

  • 24. Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.
    Thieme H, Schimmat C, Münzer G, Boxberger M, Fromm M, Pfeiffer N, Rosenthal R.
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):938-45. PubMed ID: 16505027
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study.
    Griffin BW, Williams GW, Crider JY, Sharif NA.
    J Pharmacol Exp Ther; 1997 May; 281(2):845-54. PubMed ID: 9152393
    [Abstract] [Full Text] [Related]

  • 29. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
    Sharif NA, McLaughlin MA, Kelly CR, Xu S, Crider JY, Williams GW, Parker JL.
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
    [Abstract] [Full Text] [Related]

  • 30. Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors.
    Chen J, Lu RT, Lai R, Dinh T, Paul D, Venadas S, Wheeler LA.
    Curr Eye Res; 2009 Mar; 34(3):184-95. PubMed ID: 19274525
    [Abstract] [Full Text] [Related]

  • 31. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES, Santana A, Rocha FN, Guapo GL, Costa VP.
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [Abstract] [Full Text] [Related]

  • 32. Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro.
    Davies SS, Ju WK, Neufeld AH, Abran D, Chemtob S, Roberts LJ.
    J Ocul Pharmacol Ther; 2003 Feb; 19(1):45-54. PubMed ID: 12648303
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.
    Snetkov VA, Knock GA, Baxter L, Thomas GD, Ward JP, Aaronson PI.
    J Physiol; 2006 Feb 15; 571(Pt 1):147-63. PubMed ID: 16357015
    [Abstract] [Full Text] [Related]

  • 34. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
    Woodward DF, Fairbairn CE, Krauss AH, Lawrence RA, Protzman CE.
    J Pharmacol Exp Ther; 1995 Apr 15; 273(1):285-7. PubMed ID: 7714778
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
    Ansari HR, Kaddour-Djebbar I, Abdel-Latif AA.
    Exp Eye Res; 2004 Feb 15; 78(2):285-96. PubMed ID: 14729360
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prostamides (prostaglandin-ethanolamides) and their pharmacology.
    Woodward DF, Liang Y, Krauss AH.
    Br J Pharmacol; 2008 Feb 15; 153(3):410-9. PubMed ID: 17721551
    [Abstract] [Full Text] [Related]

  • 39. [Theoretical and clinical aspects of the use of prostaglandins in glaucoma therapy].
    Wierzbowska J, Stankiewicz A.
    Klin Oczna; 2004 Feb 15; 106(3):352-9. PubMed ID: 15515325
    [Abstract] [Full Text] [Related]

  • 40. [Receptors involved in the mechanism of action of topical prostaglandines].
    Neacsu AM.
    Oftalmologia; 2009 Feb 15; 53(2):3-7. PubMed ID: 19697832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.